1Zha S, Yegnasubramanian V, Nelson WG, et al. Cyclooxygenases in cancer: progress and perspective[J]. Cancer Lett, 2004, 215 (1) : 1-20.
2Nzeako UC, Guicciardi ME, Yoon JH, et al. COX-2 inhibits Fasmediated apoptosis in cholangiocarcinoma cells [J]. Hepatology, 2002,35 (13):552- 559.
3Koga T,Shibahara K,Kabashima A,et al. Overexp ression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer [J]. Hepatogastroenterology,2004,51 (60): 1626- 1630.
同被引文献10
1Konturek PC,Konturek SJ,Brzozowski T.Gastric cancer and helicobacter pylori infection[J].J Physiol Pharmacol,2006,57(Suppl 3):51-65.
2Erkanli S,Bolat F,Kayaselcuk F,et al.COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma[J].Gynecol Oncol,2007,104(2):320-325.
4Krysan K,Merchant FH,Zhu L,et al.COX-2-dependent stabilization of survivin in non-small cell lung cancer[J].FASEB J,2004,18(1):206-208.
5Shin S,Sung BJ,Cho YS,et al.An anti-apoptotic protein human Survivin is a direct inhibitor of caspase-3 and -7[J].Biochemistry,2001,40(4):1117-1123.
6Schmitz KJ,Lang H,Wohlschlaeger J,et al.Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma[J].Virchows Arch,2007,450(2):135-141.
